Showing results (391-400 of 1,300) with videos related to

Sort By:
Pageof 130
International Journal of Cardiology|April 20, 2013
Future perspectives in transcatheter aortic valve implantationChristos V Bourantas, Nicolas M van Mieghem, Vasim Farooq, et al.
JACC. Case Reports|July 28, 2021
Hemolysis After Transcatheter Mitral Valve Implantation Resolved by Valve RetensioningDavid Reineke, Nicolas Brugger, Mirjam G Wild, et al.
Transplant Immunology|May 18, 2010
Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathwayMelinda Oroszlán, Michael Bieri, Nathalie Ligeti, et al.
International Journal of Cardiology|March 23, 2007
Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injectionIsabelle Schmid, Dominique Didier, Thomas Pfammatter, et al.
International Journal of Cardiology|May 24, 2005
Percutaneous coronary interventions in Europe 2000Florian Balmer, Martin Rotter, Mario Togni, et al.
BMJ Open|June 12, 2012
Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in NepalThomas Pilgrim, Bindu Kalesan, Prahlad Karki, et al.
International Journal of Cardiology|September 9, 2017
Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillationSteffen Gloekler, Jacqueline Saw, Konstantinos C Koskinas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 19, 2011
The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymerScot Garg, Joanna Wykrzykowska, Patrick W Serruys, et al.
The American Journal of Cardiology|February 16, 2010
The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial)Giovanna Sarno, Scot Garg, Yoshinobu Onuma, et al.
Annals of Internal Medicine|June 13, 2017
Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary InterventionRaffaele Piccolo, Giuseppe Gargiulo, Anna Franzone, et al.
Pageof 130